USP Verifies Robinson Pharma Joint Formulas

SANTA ANA, Calif.Robinson Pharma Inc. earned verification on four joint health tablet formulations from the USP DSVP (dietary supplement verification program), giving Robinson Pharma and its customers the authorization to use the USP Verified Mark (DSVP) on product labels.

USP has issued approval letters (DSVP Ref. No.: 1083100402,3,4,&5) confirming Robinson Pharmas manufactured glucosamine-based joint health formulations that include Glucosamine HCL; Glucosamine HCL with MSM; Glucosamine with Chondroitin; and Glucosamine, Chondroitin, MSM with Vitamin D products meet the requirements of the DSVP.

USP conducted audits of Robinson Pharmas facility and quality systems, including a review of staff training, manufacturing operations, supply chain qualification for all ingredients used in the manufacture of the products and the stability studies for the products post manufacturing. The USP Verification Program involves auditing, product testing, document review and continuing surveillance activities; and covers compliance with Federal cGMP (current good manufacturing practice) regulations. 

The announcement of USP DSVP compliance follows the recent news of verification of Robinson Pharma's Fish oil 30% EPA/DHA MEG-3 USP Softgels.

Robinson Pharma Inc. provides private label and contract manufacturing services for dietary supplements and pharmaceuticals